- Home
- AMLX vs SLG Comparison
AMLX vs SLG Comparison
Compare AMLX & SLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMLX | SLG |
|---|---|---|
| Founded | 2014 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.0B |
| IPO Year | 2021 | 1997 |
Fundamental Metrics
Financial Performance| Metric | AMLX | SLG |
|---|---|---|
| Price | $27.71 | $48.21 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 17 |
| Target Price | $42.36 | ★ $58.79 |
| AVG Volume (30 Days) | ★ 1.2M | 768.4K |
| Earning Date | 11-05-2026 | 10-21-2026 |
| Dividend Yield | N/A | ★ 5.14% |
| EPS Growth | ★ 65.46 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $380,786,000.00 | ★ $1,003,046,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 1612.94 | 13.18 |
| 52 Week Low | $10.83 | $34.77 |
| 52 Week High | $41.14 | $60.09 |
Technical Indicators
Market Signals| Indicator | AMLX | SLG |
|---|---|---|
| Relative Strength Index (RSI) | 36.58 | 33.35 |
| Support Level | $12.97 | $48.10 |
| Resistance Level | $34.35 | $49.85 |
| Average True Range (ATR) | 1.39 | 1.53 |
| MACD | -0.74 | -0.29 |
| Stochastic Oscillator | 9.33 | 18.21 |
Price Performance
Historical ComparisonAbout AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
About SLG SL Green Realty Corp
SL Green Realty is one of the largest Manhattan property owners and landlords, with interest in around 31.4 million square feet of wholly owned and joint-venture office space. The company has additional property exposure through its limited portfolio of well-located retail space. It operates as a real estate investment trust.